Literature DB >> 8625990

Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen.

L Fugger1, J B Rothbard, G Sonderstrup-McDevitt.   

Abstract

A panel of HLA-DRB1*0401-restricted CD4+ mouse T cell hybridomas specific for bovine type II collagen were generated from transgenic mice expressing the human HLA-DRA1*0101/-DRB1*0401 and CD4 molecules. The vast majority recognized a single peptide determinant corresponding to residues 261-273 (CII 261-273). This determinant was rapidly defined by the use of a predictive algorithm for peptide binding to DRB1*0401. CII 261-273 is conserved in bovine and human type II collagen and overlaps with an important I-A q - restricted T cell determinant in mice with collagen-induced arthritis. This study demonstrates how HLA-DR and human CD4-transgenic mice can be used to identify a T cell epitope in a potential or candidate autoantigen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625990     DOI: 10.1002/eji.1830260431

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.

Authors:  S D Patel; A P Cope; M Congia; T T Chen; E Kim; L Fugger; D Wherrett; G Sonderstrup-McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice.

Authors:  Alexei von Delwig; Daniel M Altmann; Fraser G Charlton; Norman McKie; John D Isaacs; Rikard Holmdahl; John H Robinson
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

Review 3.  Interaction between HSP73 and HLA-DRB1*0401: implications for the development of rheumatoid arthritis.

Authors:  Isabelle Auger; Jean Roudier
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Molecular mechanisms involved in the association of HLA-DR4 and rheumatoid arthritis.

Authors:  I Auger; E Toussirot; J Roudier
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

5.  Evaluating candidate autoantigens in rheumatoid arthritis.

Authors:  A P Cope; G Sønderstrup
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

Authors:  E C Andersson; B E Hansen; H Jacobsen; L S Madsen; C B Andersen; J Engberg; J B Rothbard; G S McDevitt; V Malmström; R Holmdahl; A Svejgaard; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 7.  Transgenic models of autoimmune disease.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

8.  Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis.

Authors:  B L Kotzin; M T Falta; F Crawford; E F Rosloniec; J Bill; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

9.  An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma.

Authors:  Cristina C Clement; Elvira S Cannizzo; Maria-Dorothea Nastke; Ranjit Sahu; Waldemar Olszewski; Norman E Miller; Lawrence J Stern; Laura Santambrogio
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones.

Authors:  M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.